Prostate Cancer Chemoprevention Agent Development: The National Cancer Institute, Division of Cancer Prevention Portfolio-Reference-Cited by-同舟云学术

Prostate Cancer Chemoprevention Agent Development: The National Cancer Institute, Division of Cancer Prevention Portfolio

Published:2004-02 Issue:2S Volume:171 Page:
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

PARNES HOWARD L.¹,HOUSE MARGARET G.¹,KAGAN JACOB¹,KAUSAL DAVID J.¹,LIEBERMAN RONALD¹

Affiliation:

1. From the Prostate and Urologic Cancer Research Group and Cancer Biomarkers Research Group (JK), Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference49 articles.

1. Lessons from Hereditary Colorectal Cancer

2. The fundamental role of epigenetic events in cancer

3. How many mutations are required for tumorigenesis? implications from human cancer data

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complicaciones de la biopsia transrectal de próstata en nuestro medio. Estudio multicéntrico internacional de 3.350 pacientes;Actas Urológicas Españolas;2020-04

2. Complications of transrectal prostate biopsy in our context. International multicenter study of 3350 patients;Actas Urológicas Españolas (English Edition);2020-04

3. Bioactive Natural Products From the Genus Kalanchoe as Cancer Chemopreventive Agents: A Review;Studies in Natural Products Chemistry;2019

4. Prostate cancer prevention;Cancer Prevention and Screening;2018-08-14

5. Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their Derivatives;BioMed Research International;2015